Search

Leadership
We lead the medical malpractice industry because of the leaders in our boardroom. Read biographies of The Doctors Company Board of Governors members.

Video Jan 08, 2025
An Introduction to Medical Professional Liability Insurance for Midwives
This presentation provides a detailed examination of medical professional liability insurance, specifically designed for midwives. Learn policy coverage and exclusions, as well as practical strategies to protect your practice, whether employed or practicing independently. This session also analyzes common causes of loss in midwifery claims, comparing outcomes with those of physicians.

AM Best Revises Outlooks to Positive for The Doctors Company and Subsidiaries
AM Best has revised the outlooks to positive from stable and affirmed The Doctors Company's financial strength rating (FSR) of A (Excellent) and the long-term issuer credit rating (ICR) of "a+”. The positive outlooks, FSR of A, and long-term ICR of “a+” have been affirmed for The Doctors Company, an Interinsurance Exchange, and its core subsidiaries, which collectively comprise The Doctors Company Insurance Group (TDC or TDC Group). 

Mar 07, 2023
Third-Party Litigation Funding on the Rise
Elizabeth Y. Healy, Vice President, Government and Community Relations, The Doctors Company
Third-party litigation funding injects the financial interests of outsiders into litigation, driving up settlement awards and threatening the integrity of the civil justice system.
From The Doctor’s Advocate

Professional Education
Module 3: Safe Prescribing of Opioids and CNS Depressants (Innovations and Smart Approaches in Safe Prescribing)
Learn several new concepts and innovation tips. Learn about the new CDC Guidelines about pain. This program will show how to treat pain, opioid withdrawal, and/or opioid addiction. It will show how to taper opioids and you will learn how to conduct “motivational interviewing.” You will examine multimodal approaches for chronic pain, including physical, psych-behavioral, procedural, and pharmacological modalities. You will be encouraged to use tools for prescribing and tapering opioids and benzodiazepines. You will be provided with an overview of the use of CURES 2.0. Lastly, the program will examine how to best screen patients for use of CNS depressants and marijuana to mitigate the potential for contraindications with opioids. This module consists of seven audio-filled videos. To successfully complete this course, you need to achieve a passing score of 80 percent in the post-test questions.

Stay in the Know

Sign Up for The Doctor’s Practice

Our monthly e-newsletter features timely articles, videos, and guides on a range of patient safety topics.

Subscribe